Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2019 | A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma | Qin S.; Chan S.L.; Sukeepaisarnjaroen W.; Han G.; Choo S.P.; Sriuranpong V.; Pan H.; Yau T.; Guo Y.; Chen M.; Ren Z.; Xu J.; Yen C.-J.; ZHONG-ZHE LIN ; Manenti L.; Gu Y.; Sun Y.; Tiedt R.; Hao L.; Song W.; Tanwandee T. | Therapeutic Advances in Medical Oncology | 38 | 38 | |
2011 | Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data | Tao Y.; Ruan J.; Shiou-Hwei Yeh ; Lu X.; Wang Y.; Zhai W.; Cai J.; Ling S.; Gong Q.; Chong Z.; Qu Z.; Li Q.; Liu J.; Yang J.; Zheng C.; Zeng C.; HURNG-YI WANG ; Zhang J.; Wang S.-H.; Hao L.; Dong L.; Li W.; Sun M.; Zou W.; Yu C.; Li C.; Liu G.; Jianga L.; Xu J.; Huang H.; Li C.; Mi S.; Zhang B.; Chen B.; Zhao W.; Hu S.; Zhuang S.-M.; Shen Y.; Shi S.; Brown C.; White K.P.; Chen D.-S.; PEI-JER CHEN ; Wu C.-I. | Proceedings of the National Academy of Sciences of the United States of America | 113 | 105 |